Cannabis-based products for the treatment of skin inflammatory diseases: A timely review

AM Martins, AL Gomes, I Vilas Boas, J Marto… - Pharmaceuticals, 2022 - mdpi.com
The use of natural products in dermatology is increasingly being pursued due to
sustainability and ecological issues, and as a possible way to improve the therapeutic …

Cannabis and athletic performance

JF Burr, CP Cheung, AM Kasper, SH Gillham, GL Close - Sports Medicine, 2021 - Springer
Cannabis is widely used for both recreational and medicinal purposes on a global scale.
There is accumulating interest in the use of cannabis and its constituents for athletic …

Medicinal cannabis for paediatric developmental, behavioural and mental health disorders

D Efron, K Taylor - International Journal of Environmental Research and …, 2023 - mdpi.com
Parents of children with developmental, behavioural and mental health disorders are
increasingly asking whether medicinal cannabis might be a therapeutic option for their child …

Medical cannabinoids for painful symptoms in patients with severe dementia: a randomized, double-blind cross-over placebo-controlled trial protocol

F Bianchi, S Pautex, J Wampfler, F Curtin… - Frontiers in Pain …, 2023 - frontiersin.org
Background In an observational study in Geneva (Switzerland), we found that administering
a standardized THC/CBD oil was feasible, safe, and beneficial in an elderly polymedicated …

'What price do you put on your health?': Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer

RE Olson, A Smith, P Good, M Dudley… - Health …, 2023 - Wiley Online Library
Introduction Following 2016 legislation permitting limited access to cannabis for research
and medicinal purposes, the number of randomized clinical trials (RCTs) investigating the …

Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced …

RE Olson, A Smith, G Huggett, P Good, M Dudley… - Trials, 2022 - Springer
Background Recruitment for randomised controlled trials in palliative care can be
challenging; disease progression and terminal illness underpin high rates of attrition …

[HTML][HTML] The Evolving Role of Cannabidiol-Rich Cannabis in People with Autism Spectrum Disorder: A Systematic Review

B Jawed, JE Esposito, R Pulcini, SK Zakir… - International Journal of …, 2024 - mdpi.com
Autism spectrum disorder (ASD) is a neurological disease and lifelong condition. The
treatment gap in ASD has led to growing interest in alternative therapies, particularly in …

[HTML][HTML] Clinical studies with Cannabis in India–A need for guidelines for the investigators and ethics committees

P Nayak, G Pantvaidya, P Ranganathan… - … in Clinical Research, 2023 - journals.lww.com
Cannabis is one of the world's oldest cultivated plants and the most commonly used
recreational drug worldwide. The plant relevant for medicinal use is Cannabis sativa that …

NSW Cannabis Medicines Advisory Service preliminary survey results: enquirer perceptions and patient outcomes

M Graham, S Bird, Z Howard, M Dobson… - Internal Medicine …, 2022 - Wiley Online Library
Abstract Background In 2018, an innovative, State government‐funded cannabis medicines
drug information service was established for health professionals in New South Wales …

THE APPLICATION OF CANNABIDIOL IN THE TREATMENT OF GLIOBLASTOMA.

A RYBARCZYK… - Acta Poloniae …, 2023 - search.ebscohost.com
Glioblastoma multiforme (GBM), a high-grade astrocytoma, is an incurable brain tumor
associated with genetic heterogeneity and dysregulated signaling pathways. As alternations …